NCT00119314 · Interventional trial
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
Overall registry status Withdrawn
Phase 2
Conditions Carcinoma of Unknown Primary
Delaware Valley sites
- Cancer Institute of New Jersey at Hamilton · Hamilton, NJ · Mercer County
First posted
Registry updated
Added to the directory